ArticleJournal of hepatocellular carcinoma2026
Development of a PNI-Based Prognostic Model for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib-Based Triple Therapy.
Weifu Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.